BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 35231921)

  • 1. Clinicopathological Features Associated with Microsatellite Instability/Mismatch Repair Deficiency in Uterine Carcinosarcoma: A Quantitative Systematic Review.
    Travaglino A; Raffone A; Santoro A; Raimondo D; Orsini B; Casadio P; Zullo F; Seracchioli R; Zannoni GF; Insabato L; Mollo A
    Pathobiology; 2022; 89(4):198-204. PubMed ID: 35231921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA Mismatch Repair-deficient Endometrial Carcinosarcomas Portend Distinct Clinical, Morphologic, and Molecular Features Compared With Traditional Carcinosarcomas.
    Segura SE; Pedra Nobre S; Hussein YR; Abu-Rustum NR; Weigelt B; Soslow RA; DeLair DF
    Am J Surg Pathol; 2020 Nov; 44(11):1573-1579. PubMed ID: 32804882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian endometrioid adenocarcinoma: incidence and clinical significance of the morphologic and immunohistochemical markers of mismatch repair protein defects and tumor microsatellite instability.
    Aysal A; Karnezis A; Medhi I; Grenert JP; Zaloudek CJ; Rabban JT
    Am J Surg Pathol; 2012 Feb; 36(2):163-72. PubMed ID: 22189970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microsatellite instability and mismatch repair protein defects in ovarian epithelial neoplasms in patients 50 years of age and younger.
    Jensen KC; Mariappan MR; Putcha GV; Husain A; Chun N; Ford JM; Schrijver I; Longacre TA
    Am J Surg Pathol; 2008 Jul; 32(7):1029-37. PubMed ID: 18469706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mismatch Repair Deficiency in Uterine Carcinosarcoma: A Multi-institution Retrospective Review.
    Jenkins TM; Hanley KZ; Schwartz LE; Cantrell LA; Stoler MH; Mills AM
    Am J Surg Pathol; 2020 Jun; 44(6):782-792. PubMed ID: 31934920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological and Survival Characteristics of Mismatch Repair Status and PD-1 Expression in Serous Ovarian Cancer.
    Olmez F; Oglak SC; Akgol S; Olmez OF; Bilici A; Akbayir O; Ozkose ZG; Can E; Unal O; Sirinoglu HA
    J Coll Physicians Surg Pak; 2023 Jun; 33(6):666-672. PubMed ID: 37300263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practical guidance for mismatch repair-deficiency testing in endometrial cancer.
    Stelloo E; Jansen AML; Osse EM; Nout RA; Creutzberg CL; Ruano D; Church DN; Morreau H; Smit VTHBM; van Wezel T; Bosse T
    Ann Oncol; 2017 Jan; 28(1):96-102. PubMed ID: 27742654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High homogeneity of MMR deficiency in ovarian cancer.
    Fraune C; Rosebrock J; Simon R; Hube-Magg C; Makrypidi-Fraune G; Kluth M; Büscheck F; Höflmayer D; Schmalfeldt B; Müller V; Wölber L; Witzel I; Paluchowski P; Wilke C; Heilenkötter U; von Leffern I; Clauditz TS; Wilczak W; Sauter G; Steurer S; Burandt E
    Gynecol Oncol; 2020 Mar; 156(3):669-675. PubMed ID: 31924330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mismatch repair deficiency is associated with MSI phenotype, increased tumor-infiltrating lymphocytes and PD-L1 expression in immune cells in ovarian cancer.
    Xiao X; Dong D; He W; Song L; Wang Q; Yue J; Xie L
    Gynecol Oncol; 2018 Apr; 149(1):146-154. PubMed ID: 29496294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency of mismatch repair deficiency in pancreatic ductal adenocarcinoma.
    Ahmad-Nielsen SA; Bruun Nielsen MF; Mortensen MB; Detlefsen S
    Pathol Res Pract; 2020 Jun; 216(6):152985. PubMed ID: 32360245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of pelvic inflammation-related mismatch repair abnormalities and microsatellite instability in the malignant transformation of ovarian endometriosis.
    Fuseya C; Horiuchi A; Hayashi A; Suzuki A; Miyamoto T; Hayashi T; Shiozawa T
    Hum Pathol; 2012 Nov; 43(11):1964-72. PubMed ID: 22626277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An alternative pathway in colorectal carcinogenesis based on the mismatch repair system and p53 expression in Korean patients with sporadic colorectal cancer.
    Kim HR; Kim HC; Yun HR; Kim SH; Park CK; Cho YB; Yun SH; Lee WY; Chun HK
    Ann Surg Oncol; 2013 Nov; 20(12):4031-40. PubMed ID: 22732839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological features of 50 mismatch repair (MMR)-deficient endometrial carcinomas, tested by immunohistochemistry: A single institutional feasibility study, India.
    Rekhi B; Menon S; Deodhar KK; Ghosh J; Chopra S; Maheshwari A
    Ann Diagn Pathol; 2020 Aug; 47():151558. PubMed ID: 32619922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular analysis of Iranian colorectal cancer patients at risk for Lynch syndrome: a new molecular, clinicopathological feature.
    Zeinalian M; Emami MH; Salehi R; Naimi A; Kazemi M; Hashemzadeh-Chaleshtori M
    J Gastrointest Cancer; 2015 Jun; 46(2):118-25. PubMed ID: 25722176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The histomorphology of Lynch syndrome-associated ovarian carcinomas: toward a subtype-specific screening strategy.
    Chui MH; Ryan P; Radigan J; Ferguson SE; Pollett A; Aronson M; Semotiuk K; Holter S; Sy K; Kwon JS; Soma A; Singh N; Gallinger S; Shaw P; Arseneau J; Foulkes WD; Gilks CB; Clarke BA
    Am J Surg Pathol; 2014 Sep; 38(9):1173-81. PubMed ID: 25025451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Prevalence and Prognosis of Microsatellite Instability-High/Mismatch Repair-Deficient Colorectal Adenocarcinomas in the United States.
    Gutierrez C; Ogino S; Meyerhardt JA; Iorgulescu JB
    JCO Precis Oncol; 2023 Jan; 7():e2200179. PubMed ID: 36716414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defective DNA mismatch repair and XRCC2 mutation in uterine carcinosarcomas.
    Taylor NP; Gibb RK; Powell MA; Mutch DG; Huettner PC; Goodfellow PJ
    Gynecol Oncol; 2006 Jan; 100(1):107-10. PubMed ID: 16169065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of 108 patients with endometrial carcinoma using the PROMISE classification and additional genetic analyses for MMR-D.
    Timmerman S; Van Rompuy AS; Van Gorp T; Vanden Bempt I; Brems H; Van Nieuwenhuysen E; Han SN; Neven P; Victoor J; Laenen A; Vergote I
    Gynecol Oncol; 2020 Apr; 157(1):245-251. PubMed ID: 31980219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histopathologic features and microsatellite instability of cancers of the papilla of vater and their precursor lesions.
    Ruemmele P; Dietmaier W; Terracciano L; Tornillo L; Bataille F; Kaiser A; Wuensch PH; Heinmoeller E; Homayounfar K; Luettges J; Kloeppel G; Sessa F; Edmonston TB; Schneider-Stock R; Klinkhammer-Schalke M; Pauer A; Schick S; Hofstaedter F; Baumhoer D; Hartmann A
    Am J Surg Pathol; 2009 May; 33(5):691-704. PubMed ID: 19252434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of microsatellite instability in endometroid carcinoma with deficient mismatch repair].
    Zhang YH; Wu HW; Wang J; Liang ZY
    Zhonghua Bing Li Xue Za Zhi; 2021 May; 50(5):470-475. PubMed ID: 33915653
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.